End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
0.12 SEK | -6.98% | +9.09% | -65.71% |
Valuation
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Capitalization 1 | 33.3 | 32.3 | 42.4 | 47.29 | 52.78 | 24.08 |
Enterprise Value (EV) 1 | 32.78 | 23.34 | 39.89 | 41.74 | 51.82 | 26.03 |
P/E ratio | -2.59 x | -3.42 x | -5.27 x | -6.73 x | -13.7 x | -4.13 x |
Yield | - | - | - | - | - | - |
Capitalization / Revenue | 7.27 x | 4.18 x | 7.4 x | 6.02 x | 6.39 x | 2.93 x |
EV / Revenue | 7.16 x | 3.02 x | 6.96 x | 5.31 x | 6.28 x | 3.17 x |
EV / EBITDA | -2.56 x | -2.53 x | -5.12 x | -7.18 x | -15.2 x | -4.9 x |
EV / FCF | -1.28 x | 2.04 x | -9.86 x | -7.38 x | -16.6 x | -4.16 x |
FCF Yield | -78% | 49% | -10.1% | -13.5% | -6.03% | -24% |
Price to Book | 1.42 x | 2.49 x | 7.67 x | 4.91 x | 9.16 x | 4.43 x |
Nbr of stocks (in thousands) | 27,296 | 45,493 | 46,188 | 50,038 | 57,188 | 57,188 |
Reference price 2 | 1.220 | 0.7100 | 0.9180 | 0.9450 | 0.9230 | 0.4210 |
Announcement Date | 4/30/18 | 4/29/19 | 4/23/20 | 4/20/21 | 5/4/22 | 5/10/23 |
Income Statement Evolution (Annual data)
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net sales 1 | 4.58 | 7.729 | 5.733 | 7.861 | 8.259 | 8.221 |
EBITDA 1 | -12.79 | -9.211 | -7.788 | -5.809 | -3.405 | -5.313 |
EBIT 1 | -12.97 | -9.381 | -8.031 | -6.12 | -3.837 | -5.755 |
Operating Margin | -283.22% | -121.38% | -140.09% | -77.85% | -46.46% | -70% |
Earnings before Tax (EBT) 1 | -12.83 | -9.434 | -8.05 | -7.029 | -3.861 | -5.833 |
Net income 1 | -12.83 | -9.434 | -8.05 | -7.029 | -3.861 | -5.833 |
Net margin | -280.22% | -122.07% | -140.41% | -89.42% | -46.75% | -70.96% |
EPS 2 | -0.4701 | -0.2074 | -0.1743 | -0.1405 | -0.0675 | -0.1020 |
Free Cash Flow 1 | -25.58 | 11.43 | -4.046 | -5.653 | -3.123 | -6.254 |
FCF margin | -558.52% | 147.92% | -70.57% | -71.91% | -37.81% | -76.07% |
FCF Conversion (EBITDA) | - | - | - | - | - | - |
FCF Conversion (Net income) | - | - | - | - | - | - |
Dividend per Share | - | - | - | - | - | - |
Announcement Date | 4/30/18 | 4/29/19 | 4/23/20 | 4/20/21 | 5/4/22 | 5/10/23 |
Balance Sheet Analysis
Fiscal Period: December | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 |
---|---|---|---|---|---|---|
Net Debt 1 | - | - | - | - | - | 1.95 |
Net Cash position 1 | 0.52 | 8.96 | 2.51 | 5.55 | 0.96 | - |
Leverage (Debt/EBITDA) | - | - | - | - | - | -0.3678 x |
Free Cash Flow 1 | -25.6 | 11.4 | -4.05 | -5.65 | -3.12 | -6.25 |
ROE (net income / shareholders' equity) | -61.7% | -51.8% | -87.1% | -92.8% | -50.2% | -104% |
ROA (Net income/ Total Assets) | -35.5% | -28.4% | -45% | -37.1% | -22.3% | -38% |
Assets 1 | 36.14 | 33.17 | 17.88 | 18.95 | 17.28 | 15.33 |
Book Value Per Share 2 | 0.8600 | 0.2800 | 0.1200 | 0.1900 | 0.1000 | 0.0900 |
Cash Flow per Share 2 | 0.0200 | 0.2000 | 0.0500 | 0.1500 | 0.0200 | 0.0100 |
Capex | - | 0.37 | 0.32 | 0.54 | 0.12 | - |
Capex / Sales | - | 4.78% | 5.51% | 6.92% | 1.46% | - |
Announcement Date | 4/30/18 | 4/29/19 | 4/23/20 | 4/20/21 | 5/4/22 | 5/10/23 |
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA
1st Jan change | Capi. | |
---|---|---|
-65.71% | 626K | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+0.65% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- ALTE Stock
- Financials Alteco Medical AB